Parametric Portfolio Associates’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-43
| Closed | -$110K | – | 3751 |
|
|
2021
Q4 | $110K | Sell |
43
-6
| -12% | -$15.3K | ﹤0.01% | 3539 |
|
|
2021
Q3 | $222K | Buy |
49
+3
| +7% | +$13.6K | ﹤0.01% | 3398 |
|
|
2021
Q2 | $315K | Buy |
46
+3
| +7% | +$20.5K | ﹤0.01% | 3252 |
|
|
2021
Q1 | $315K | Buy |
43
+9
| +26% | +$65.9K | ﹤0.01% | 3697 |
|
|
2020
Q4 | $277K | Buy |
34
+1
| +3% | +$8.15K | ﹤0.01% | 3633 |
|
|
2020
Q3 | $338K | Buy |
33
+5
| +18% | +$51.2K | ﹤0.01% | 3437 |
|
|
2020
Q2 | $186K | Buy |
28
+3
| +12% | +$19.9K | ﹤0.01% | 3647 |
|
|
2020
Q1 | $113K | Buy |
25
+14
| +127% | +$63.3K | ﹤0.01% | 3704 |
|
|
2019
Q4 | $68K | Buy |
+11
| New | +$68K | ﹤0.01% | 3906 |
|